Tabula Rasa HealthCare Inc (TRHC) to Post FY2018 Earnings of $0.43 Per Share, William Blair Forecasts

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) – Equities research analysts at William Blair dropped their FY2018 EPS estimates for shares of Tabula Rasa HealthCare in a report issued on Tuesday, December 4th. William Blair analyst R. Daniels now forecasts that the company will post earnings of $0.43 per share for the year, down from their prior forecast of $0.45.

Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its quarterly earnings data on Tuesday, November 6th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.19 by $0.07. Tabula Rasa HealthCare had a positive return on equity of 7.63% and a negative net margin of 13.49%. The business had revenue of $54.42 million during the quarter, compared to analyst estimates of $52.87 million. During the same period last year, the company earned $0.08 earnings per share. Tabula Rasa HealthCare’s quarterly revenue was up 66.3% compared to the same quarter last year.



Several other analysts have also issued reports on TRHC. Zacks Investment Research lowered Tabula Rasa HealthCare from a “hold” rating to a “sell” rating in a report on Saturday, November 10th. BidaskClub upgraded Tabula Rasa HealthCare from a “hold” rating to a “buy” rating in a report on Wednesday, November 28th. Piper Jaffray Companies reiterated an “overweight” rating and set a $80.00 price objective on shares of Tabula Rasa HealthCare in a report on Thursday. Chardan Capital increased their price objective on Tabula Rasa HealthCare from $77.00 to $91.00 and gave the stock a “buy” rating in a report on Wednesday, November 7th. Finally, Cantor Fitzgerald reiterated a “buy” rating and set a $99.00 price objective on shares of Tabula Rasa HealthCare in a report on Tuesday, November 6th. Two equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Tabula Rasa HealthCare has an average rating of “Buy” and an average price target of $82.50.

Shares of NASDAQ:TRHC opened at $73.49 on Thursday. The company has a quick ratio of 0.46, a current ratio of 0.49 and a debt-to-equity ratio of 0.28. Tabula Rasa HealthCare has a 1 year low of $27.31 and a 1 year high of $91.16. The firm has a market cap of $1.48 billion, a P/E ratio of -1,837.25, a PEG ratio of 6.84 and a beta of 2.53.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. American International Group Inc. raised its holdings in Tabula Rasa HealthCare by 6.0% during the third quarter. American International Group Inc. now owns 13,664 shares of the company’s stock valued at $1,109,000 after buying an additional 772 shares in the last quarter. Teachers Advisors LLC grew its position in shares of Tabula Rasa HealthCare by 2.6% in the third quarter. Teachers Advisors LLC now owns 34,204 shares of the company’s stock valued at $2,777,000 after purchasing an additional 863 shares during the last quarter. Chicago Equity Partners LLC grew its position in shares of Tabula Rasa HealthCare by 6.4% in the third quarter. Chicago Equity Partners LLC now owns 15,050 shares of the company’s stock valued at $1,222,000 after purchasing an additional 900 shares during the last quarter. State of Alaska Department of Revenue grew its position in shares of Tabula Rasa HealthCare by 22.4% in the third quarter. State of Alaska Department of Revenue now owns 5,445 shares of the company’s stock valued at $442,000 after purchasing an additional 995 shares during the last quarter. Finally, Louisiana State Employees Retirement System grew its position in shares of Tabula Rasa HealthCare by 21.3% in the third quarter. Louisiana State Employees Retirement System now owns 7,400 shares of the company’s stock valued at $601,000 after purchasing an additional 1,300 shares during the last quarter. Institutional investors own 74.88% of the company’s stock.

In other Tabula Rasa HealthCare news, Director Gordon Tunstall sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, November 28th. The stock was sold at an average price of $70.52, for a total transaction of $705,200.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, President Orsula V. Knowlton sold 8,000 shares of the firm’s stock in a transaction dated Wednesday, October 17th. The shares were sold at an average price of $81.01, for a total value of $648,080.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 50,000 shares of company stock worth $3,655,920. Corporate insiders own 14.00% of the company’s stock.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Further Reading: Stock Selection – What is cash flow?

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply